Diagnosis of early gastric cancer

Ari Ristimäki; Matti Harkonen; Pentti Ilmari Sipponen

Diagnosis of early gastric cancer

Ari Ristimäki, Matti Harkonen, Pentti Ilmari Sipponen

Gastrointestinal tumorigenesis

Forskningsoutput: Patent

Sammanfattning

The present invention pertains to a method for determination of the significance of a histologically detected premalignant lesion as a risk for intestinal type gastric cancer or carcinoma in situ, comprising detecting from a patient sample comprising gastric mucosa cells a) cyclooxygenase-2 Cox-2) mRNA expression, or b) Cox-2 protein; wherein overexpression of Cox-2 is indicative of an increased risk for intestinal type gastric cancer.

Originalspråk	engelska
Utgivningsår	9 jul 2002
Status	Publicerad - 9 jul 2002
MoE-publikationstyp	H1 Beviljat patent

Vetenskapsgrenar

312 Klinisk medicin

Åtkomst av dokument

http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=26&f=G&l=50&co1=AND&d=PTXT&s1=%22early+gastric+cancer%22&OS=%22early+gastric+cancer%22&RS=%22early+gastric+cancer%22

Citera det här

@misc{a1d357e093d949a8b62fd63fd62a89e2,

title = "Diagnosis of early gastric cancer",

abstract = "The present invention pertains to a method for determination of the significance of a histologically detected premalignant lesion as a risk for intestinal type gastric cancer or carcinoma in situ, comprising detecting from a patient sample comprising gastric mucosa cells a) cyclooxygenase-2 Cox-2) mRNA expression, or b) Cox-2 protein; wherein overexpression of Cox-2 is indicative of an increased risk for intestinal type gastric cancer. ",

keywords = "312 Clinical medicine",

author = "Ari Ristim{\"a}ki and Matti Harkonen and Sipponen, {Pentti Ilmari}",

year = "2002",

month = jul,

day = "9",

language = "English",

type = "Patent",

note = "US patent 6,416,961; C12Q 1/68 (20060101)",

}

TY - PAT

T1 - Diagnosis of early gastric cancer

AU - Ristimäki, Ari

AU - Harkonen, Matti

AU - Sipponen, Pentti Ilmari

PY - 2002/7/9

Y1 - 2002/7/9

N2 - The present invention pertains to a method for determination of the significance of a histologically detected premalignant lesion as a risk for intestinal type gastric cancer or carcinoma in situ, comprising detecting from a patient sample comprising gastric mucosa cells a) cyclooxygenase-2 Cox-2) mRNA expression, or b) Cox-2 protein; wherein overexpression of Cox-2 is indicative of an increased risk for intestinal type gastric cancer.

AB - The present invention pertains to a method for determination of the significance of a histologically detected premalignant lesion as a risk for intestinal type gastric cancer or carcinoma in situ, comprising detecting from a patient sample comprising gastric mucosa cells a) cyclooxygenase-2 Cox-2) mRNA expression, or b) Cox-2 protein; wherein overexpression of Cox-2 is indicative of an increased risk for intestinal type gastric cancer.

KW - 312 Clinical medicine

M3 - Patent

M1 - US patent 6,416,961

Y2 - 2002/07/09

ER -